Clinical Study Agreement Template for Australia

When conducting clinical trials in Australia, you need a comprehensive Clinical Study Agreement to establish clear legal relationships between all parties involved. This critical contract governs the collaboration between pharmaceutical companies, research institutions, principal investigators, and other stakeholders while ensuring compliance with Australian regulatory requirements.

When do you need this document?

You require a Clinical Study Agreement whenever initiating clinical research involving therapeutic goods, medical devices, or pharmaceutical products in Australia. This includes Phase I through Phase IV trials, bioequivalence studies, post-market surveillance studies, and investigator-initiated trials. The agreement is essential when multiple parties collaborate on research, whether you're a sponsor seeking to engage research sites, a hospital entering into research partnerships, or a principal investigator conducting sponsored studies. International sponsors must use this agreement to ensure Australian regulatory compliance, while local institutions need it to protect their interests and define operational responsibilities.

Key legal considerations

Your Clinical Study Agreement must address several critical legal elements to protect all parties and ensure successful trial conduct. Financial provisions should clearly define payment schedules, budget allocations, and cost responsibilities for protocol amendments or early termination. Intellectual property clauses must specify ownership of study data, inventions, and publications, particularly important for collaborative research. Indemnification provisions should allocate liability between sponsors and institutions, covering participant injury, regulatory non-compliance, and protocol violations. Data protection clauses must ensure compliance with privacy laws, defining data ownership, storage requirements, and permitted uses. The agreement should include detailed termination provisions, specifying conditions for early study closure and obligations for data transfer, participant care, and regulatory reporting.

Legal requirements in Australia

Your Clinical Study Agreement must comply with the Therapeutic Goods Act 1989, which mandates TGA approval for most clinical trials involving therapeutic goods. You must ensure the agreement addresses Human Research Ethics Committee (HREC) approval requirements under the National Statement on Ethical Conduct in Human Research. Privacy Act 1988 compliance is mandatory for handling participant health information, requiring specific data protection measures and consent procedures. The agreement must incorporate ICH Good Clinical Practice guidelines, which Australia has adopted as the standard for clinical trial conduct. You should include provisions for CTN (Clinical Trial Notification) or CTA (Clinical Trial Approval) requirements depending on your study type. The contract must address Australian insurance requirements for clinical trials, including participant injury coverage and professional indemnity protection. Additionally, ensure compliance with state-specific regulations and institutional requirements that may apply to your research sites.